Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

64.93
Delayed Data
As of May 24
 +0.38 / +0.59%
Today’s Change
55.10
Today|||52-Week Range
66.80
+10.29%
Year-to-Date
Merck's (MRK) Keytruda Gets FDA Nod for Solid Tumor Cancers
May 24 / Zacks.com - Paid Partner Content
Company News for May 19, 2017
May 19 / Zacks.com - Paid Partner Content
AstraZeneca's Bydureon Fails to Reduce Cardiovascular Risk
May 24 / Zacks.com - Paid Partner Content
Merck's (MRK) Keytruda Gets FDA Nod for Two New Indications
May 19 / Zacks.com - Paid Partner Content
Merck Presents Phase II Data on Chronic Cough Candidate
May 23 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: J&J's Pharma Pipeline Update, Shire's HAE Data & More
May 19 / Zacks.com - Paid Partner Content
Edward Owens Buys Abbott Labs, Sells Allergan, Amgen, Aetna
May 23 / GuruFocus News - Paid Partner Content
Incyte (INCY) Announces Positive Data on Enzyme Inhibitor
May 18 / Zacks.com - Paid Partner Content
Merck Declares 47 Cent Quarterly Dividend
May 23 / TheStreet.com - Paid Partner Content
US Market Indexes Higher on Thursday
May 18 / GuruFocus News - Paid Partner Content
Merck & Co Faces Financial Hit From U.K. Regulator Over Drug Pricing
May 23 / TheStreet.com - Paid Partner Content
Immune Design (IMDZ) Posts Narrower-than-Expected Loss in Q1
May 18 / Zacks.com - Paid Partner Content
Novartis' (NVS) Lung Cancer Drug Gets Positive CHMP Opinion
May 22 / Zacks.com - Paid Partner Content
4 Large-Cap Drug Stocks To Buy Post Q1 Earnings
May 18 / Zacks.com - Paid Partner Content
Merck vs. Sanofi: Which Stock is a Better Pick Post Q1 Earnings?
May 22 / Zacks.com - Paid Partner Content
5 Reasons Why Merck (MRK) is a Good Stock to Buy Now
May 17 / Zacks.com - Paid Partner Content
Merck's HIV Drug Gets Positive CHMP Opinion for Higher Dose
May 22 / Zacks.com - Paid Partner Content
AstraZeneca Imfinzi Positive in Phase III Lung Cancer Study
May 15 / Zacks.com - Paid Partner Content
Amgen Evenity Approval Derailed on Cardiovascular Side Effect
May 22 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Mylan, Teva Q1 Earnings, Roche Drug Misses in Pivotal Study
May 12 / Zacks.com - Paid Partner Content
Howard Marks on the Truth About Investing
May 19 / GuruFocus News - Paid Partner Content
The Zacks Analyst Blog Highlights: Merck, Barclays, Activision Blizzard, Blackstone a...
May 11 / Zacks.com - Paid Partner Content
Independent Advisor Alliance Buys Vanguard Total Stock Market, iShares Core U.S. ...
May 19 / GuruFocus News - Paid Partner Content
Apple's pile of cash; Health care earnings; Infosys hiring spree
May 02 / CNNMoney.com